StreetAlpha.app
Home › Stocks › GEHC

GE HealthCare Technologies Inc. (GEHC)

Healthcare
$81.84
▼ −1.35%
LAST CLOSE · NOV 17

GE HealthCare sells medical imaging, patient monitoring, ultrasound and diagnostic products and services to healthcare providers. It last closed at $81.84 on Nov 17, down 1.35% on the day. GEHC reports earnings on Wed, Feb 3, 2027. The average 12-month price target from 8 analysts is $88.75 (+8.4% from the last close), with a high of $110.00 and a low of $79.00. Analyst consensus is Buy, based on the latest ratings from 8 firms (5 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 2 whale options trades in GEHC, 100% of them bullish and 0% bearish. In the past 30 days there were 7 dark pool prints totaling $9.7M, the largest $3.5M.

AI Auto Pilots
Is GEHC in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$21.6B
+6.9% vs a year ago
Net income
$2.2B
−2.8% vs a year ago
EPS (diluted)
$4.73
−2.1% vs a year ago
Gross margin
39.9%
$8.6B gross profit
Valuation
Market cap
$37.0B
452.1M shares
P/E
17.3
Price over 12 month EPS
Price to sales
1.7
Market cap over revenue
Dividend yield
0.18%
$0.15 a share over 12 months
Balance sheet
Cash & equivalents
$2.8B
At Sep 30
Debt
$10.0B
At Sep 30
Shareholder equity
$11.6B
Buybacks
$300.0M
Last 12 months
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $17.6B$17.6BFY2021FY2022: $18.3B$18.3BFY2022FY2023: $19.6B$19.6BFY2023FY2024: $19.7B$19.7BFY2024FY2025: $20.6B$20.6BFY2025

From GEHC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 28). Last 12 months adds up the four latest quarters.

Next report
Feb 3
2027 · Time not announced
Consensus EPS forecast
$1.55
$5.92B revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
Buy
Based on 8 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Buy
8firms
5 Buy3 Hold0 Sell
Each firm's latest rating on GEHC in the past 90 days
Average 12-month target
$88.75
▲ 8.4% upside

Based on 8 analysts who set a price target on GEHC in the past 90 days. The average target is $88.75, with a high of $110.00 and a low of $79.00, compared with the last close of $81.84.

Low $79.00Avg $88.75High $110.00
Blue marker: last close $81.84
Highest target$110.00
Average target$88.75
Lowest target$79.00
Latest rating changes
Argus ResearchMaintained
Nov 11Buy$110
UBSTarget raised
Nov 3Hold$73 → $80
JP MorganMaintained
Oct 29Hold$80
CitigroupTarget raised
Oct 29Hold$71 → $79
RBC CapitalMaintained
Oct 29Buy$90
DateFirmActionRatingPrice target
Nov 11Argus ResearchMaintainedBuy$110
Nov 3UBSTarget raisedHold$73 → $80
Oct 29JP MorganMaintainedHold$80
Oct 29CitigroupTarget raisedHold$71 → $79
Oct 29RBC CapitalMaintainedBuy$90
Loading…

Technical Analysis

GEHC · as of the Nov 17 close · updated after every close
Uptrend, nearing overbought

The stock is 4% above its 20 day and 13% above its 50 day average. It is 15% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 63), near overbought. The nearest support is the Pivot S1 at $81.21, and the nearest resistance the Pivot at $82.42.

Short trendBullish
Long trendBullish
MomentumImproving
StretchNear overbought
VolatilityNormal, 2.7%/day
Key levels
$89.7752 week high+9.7%
$87.56Swing high (Nov 4)+7.0%
$83.06Pivot R1+1.5%
$82.42Pivot+0.7%
$81.84Last close
$81.21Pivot S1−0.8%
$78.7920 day average−3.7%
$71.1350 day average−13.1%
$69.96200 day average−14.5%
$69.72100 day average−14.8%
$68.70Swing low (Oct 21)−16.1%
$58.7552 week low−28.2%
Indicators
RSI (14)63.45Strong, overbought above 70Neutral
MACD3.57Below its signal lineBearish
Stochastic63.8Middle of its rangeNeutral
ADX (14)51.1Strong uptrend
Williams %R-47.0Oversold below −80, overbought above −20Neutral
CCI (20)52.3Oversold below −100, overbought above 100Neutral
Rate of change+1.5%Change over 10 sessionsBullish
ATR (14)$2.21Typical daily range, 2.7% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for GEHC

What happened before

See how GEHC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow GEHC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How GEHC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2022.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Total alerts
2
Bullish
2
100%
Bearish
0
0%
Date span
Oct 30 – Nov 10
Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
7
Notional
$9.7M
Largest print
$3.5M
Loading…

GEHC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●534 buying vs 518 selling
  • ▲Held by funds +2.1 pts
  • ●Funds holding -10
  • ▼Superinvestors: 1 added, 3 cut
  • ▼Put/call 0.81 to 0.86
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1,2221,232−0.8%
In funds' top 10116+83.3%
Held by funds89.5%87.4%+2.1 pts
New / increased110 / 424115 / 395+4.7%
Reduced / sold out407 / 111470 / 166−18.6%
Put/call ratio0.860.81+5.7%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See GEHC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

GEHC Stock Buybacks

See all S&P 500 buybacks →
Spent, 12 months
$300.0M
0.8% yield
Left in program
$500.0M
1.4% of value
Shares outstanding, 12 months
−0.7%
Fewer shares
Last quarter
—
Sep 2026
Avg price paid, last quarter
—
 
S&P 500 rank by spending
#312 of 358
 
Spent each quarter, last 3 yearsTop bar $200.0M
Dec 2023: $0Mar 2024: $0Jun 2024: $0Sep 2024: $0Dec 2024: $0Mar 2025: $0Jun 2025: $100.0M, average price $70.06Sep 2025: $100.0M, average price $71.98Dec 2025: $0Mar 2026: $100.0M, average price $71.35Jun 2026: $200.0M, average price $61.05Sep 2026: $0
Dec 2023Sep 2026
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.

From the company's 10-Q filed Oct 28, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GEHC is in one of them and how their past GEHC trades turned out.

GEHC in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered GEHC in an article yet. Here's the latest on the wider market.

GEHC Congress Trades

All congress trades →
Trades, 12 months
38
Buys
24
63%
Sells
14
37%
People
5
Last filed Nov 5
Who traded GEHC · since 2023
Latest 5 filings of 61
$1K – $15KTraded Oct 8, 2026Filed Nov 5, 2026
$1K – $15KTraded Oct 7, 2026Filed Nov 5, 2026
$1K – $15KTraded Sep 11, 2026Filed Oct 7, 2026
$15K – $50KTraded Aug 26, 2026Filed Sep 22, 2026
$1K – $15KTraded Aug 17, 2026Filed Sep 22, 2026
PersonTypeAmountTradedFiledDelay
Ro KhannaD · CABuy$1K – $15KOct 8, 2026Nov 5, 202628 d
Ro KhannaD · CASell$1K – $15KOct 7, 2026Nov 5, 202629 d
Ro KhannaD · CABuy$1K – $15KSep 11, 2026Oct 7, 202626 d
Donald J TrumpExecutive branchSell$15K – $50KAug 26, 2026Sep 22, 202627 d
Donald J TrumpExecutive branchBuy$1K – $15KAug 17, 2026Sep 22, 202636 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About GE HealthCare Technologies

GE HealthCare makes medical technology used to diagnose and treat patients, and its headquarters are in Chicago, Illinois. Its products include CT, MR, X-ray and molecular imaging systems, ultrasound equipment, patient monitors, ECG devices, and maternal and anesthesia care equipment. It also sells pharmaceutical diagnostics, software, digital tools and related services. Its customers are hospitals, health systems, imaging centers and researchers, including public, private, academic and government institutions.

Headquarters
Chicago, IL